The role of d-dimer as first marker of thrombophilia in women affected by sterility: Implications in pathophysiology and diagnosis of thrombophilia induced sterility

Journal of Translational Medicine

Volumn 2, Issue , 2004, Pages

  Di Micco, Pierpaolo ^a   D'Uva, Maristella ^b   Strina, Ida ^b   Mollo, Antonio ^b   Amato, Valeria ^b   Niglio, Alferio ^a   De Placido, Giuseppe ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Alteration of haemostasis; D dimer; Recurrent fetal loss; Sterility; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN III; BIOCHEMICAL MARKER; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; D DIMER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN;

ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN III DEFICIENCY; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; FEMALE; FEMALE INFERTILITY; FEMALE STERILITY; FETUS WASTAGE; FIBRINOLYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; HYPERCOAGULABILITY; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN C DEFICIENCY; RECURRENT DISEASE; SCREENING TEST; STATISTICAL SIGNIFICANCE; THROMBOPHILIA; THROMBOSIS;

EID: 18144389116     PISSN: 14795876     EISSN: None     Source Type: Journal    
DOI: 10.1186/1479-5876-2-38     Document Type: Article

References (46)

1. Perrier A, Bounameaux H: Cost-effective diagnosis of depp vein thrombosis and pulmonary embolism. Thromb Haemost 2001, 86:475-487.
2. Arkel YS, Paidas MJ, Ku DH: The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders. Blood Coagul Fibrinolysis 2002, 13:199-205.
3. Le Blanche AF, Siguret V, Settegrana C, Bohus S, Le Masne de Chermont E, Andreux JP, et al.: Ruling out deep vein thrombosis by ELISA plasma D-Dimer assay versus ultra sound in inpatients more than 70 years old. Angiology 1999, 50:873-882.
4. Francalanci I, Comeglio P, Alessandrello Liotta A, Cellai AP, Fedi S, Parretti E, mecacci F, Mello G, Prisco D, Abbate R: D-Dimer plasma levels during normal pregnancy measured by specific ELISA. Int J Clin Lab Res 1997, 27:65-67.
5. Kinasewitz GT, Yan SB, Basson B, Comp P, Russel JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF, for the PROWESS Sepsis study group: Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care 2004, 8:R82-R90.
6. So AK, Varisco PA, Kemkes-Matthes B, Herkenne-Morard C, Chobas-Peclat V, Gerster JC, Busso N: Arthritis is linked to local and systemic activation and fibrinolysis pathways. J Thromb Haemost 2003, 1:2510-2515.
7. Di Micco P, De Lucia D, De Vita F, Niglio A, Di Micco G, Martinelli E, Chirico G, D' Uva M, Torella R: Acquired cancer-related thrombophilia testified by increased levels of prothrombin frament 1+2 and d-dimer in patients affected by solid tumors. Experimental Oncology 2002, 24:108-111.
8. Derhaschnig U, Laggner AN, Roggla M, Hirschl MM, Kapiotis S, Marsik C, Jilma B: Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in emergency room. Clin Chem 2002, 48:1924-1930.
9. Bounameaux H, de Moerloose P, Perrier A, Reber G: Plasma measurement of D-Dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994, 71:1-6.
10. Wells PS, Anderson DR: Diagnosis of deep-vein thrombosis in the year 2000. Curr Opin Pulm Med 2000, 6:309-313.
11. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs J: Evaluation of DDimer in the diagnosis of suspected deep-vein thrombosis. N Eng J Med 2003, 349:1227-1235.
12. Eldor A: Thrombophilia, thrombosis and pregnancy. Thromb Haemost 2001, 86:104-111.
13. Infante-Rivard C, David M, Gauthier R, Rivard GE: Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case control study. N Engl J Med 1991, 325:1063-1066.
14. Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hunt BJ, Hughes GR: A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996, 14: 31-136.
15. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G: Factor V-Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997, 77: 22-824.
16. Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, Blumenfeld Z: Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 1997, 97:551-554.
17. Brenner B, Blumenfeld Z: Thrombophilia and fetal loss. Blood Reviews 1997, 11:72-79.
18. Sarig G, Lanir N, Hoffman R, Brenner B: Protein C global assay in the evaluation of women with idiopathic pregnancy loss. Thromb Haemost 2002, 88:32-36.
19. Sarig G, Younis JS, Hoffman R, Lanir N, Blumfeld Z, Brenner B: Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002, 77:342-347.
20. Preston FE, Rosendaal FR, Walker I, Briet E, Berntorp E, Canard J, Fontcuberta J, Ma kris M, Mariani G, Noteboom W, Pabinger I, Legnani C, Scharrer I, Schulman S, van der Meer FJ: Increased fetal loss in women with heritable thrombophilia. Lancet 1996, 348: 13-916.
21. Martinelli I: Risk factors in venous thromboembolism. Thromb Haemost 2001, 86:395-403.
22. Di Micco P, Niglio A, De Renzo A, Lucania A, Di Fiore R, Scudiero O, Castaldo G: Congenital and acquired thrombotic risk factors in lymphoma patients bearing upper extremities deep venous thrombosis: a preliminary report. J Transl Med 2004, 2:7.
23. Humphries SE, Henry JA, Montgomery HE: Gene-enviroment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Blood Coagul Fibrinolysis 1999, 10(Suppl 1):S17-S21.
24. Brenner B, Sarig J, Weiner Z, Younis J, Blumenfeld Z, Lanir N: Thrombotic polimorphisms are common in women with fetal loss without cause. Thromb Haemost 1999, 82:6-9.
25. Brenner B: Inherited thrombophilia and pregnancy loss. Thromb Haemost 1999, 82:634-640.
26. Legnani C: La diagnosi di tromboembolia venosa (ruolo del ddimero) e monitoraggio della terapia. Haematologica 2003, 88(Suppl 7):11-12. Italian
27. Galli M: New advances in the mechanism of thrombosis due to antiphospholipid antibodies. [Abstract]. Pathophysiol Haemost Thromb 2002, 32(Suppl 2):22.
28. Nolan TE, Smith RP, Devoe LD: Maternal plasma d-dimer level in normal and complicated pregnancy. Obstet Gynecol 1993, 81:265-268.
29. Francalanci I, Comeglio P, Alessandrello Liotta A, Cellai AP, Fedi, Parretti E, Mello G, Prisco D, Abbate R: D-Dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res 1995, 78:399-405.
30. Di Micco P, D'Uva M, Romano M, Di Micco B, Niglio A: Stroke due to left carotid thrombosis in moderate ovarian hyperstimulation syndrome. Thromb Haemost 2003, 90: 57-960.
31. Rogolino A, Coscia ME, Fedi S, Gori AM, Cellai AP, Scarselli GF, Prisco D, Abbate R: Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagul Fibrinolysis 2003, 14:277-282.
32. Miyaishi S, Kitao T, Yamamoto Y, Ishizu H, Matsumoto T, Mizutani Y, Heinemann A, Puschel K: Identification of menstrual blood by the simultaneous determination of FDP-Ddimer and myoglobin contents. Nippon Hoigaku Zasshi 1996, 50:400-403.
33. Dossenbach-Glaninger A, Van Trotsenburg M, Dossenbach M, Oberkanins C, Morits A, Krugluger W, Huber J, Hopmeier P: Plasminogen Activator Inhibitor I 4G/5G polymorphism and Coagulation Factor XIII Val34Leu Polymorphism: Impaired Fibrinolysis and Early Pregnancy Loss. Clin Chem 2003, 49:1081-1086.
34. Carp H, Dardik R, Lubetsky A, Salomon O, Eskaraev R, Rosenthal E, Inbal A: Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study. Hum Reprod 2004, 19:191-195.
35. Azem F, Many A, Yovel I, Amit A, Lessing JB, Kupfermic MJ: Increased rate of thrombophilia in women with repeated IVF failures. Hum Reprod 2004, 19:368-370.
36. Martinelli I, Taioli E, Ragni G, Levi-Setti P, Passamonti SM, Battaglioli T, Lodigiani C, Mannucci PM: Embryo implantation after assisted reproductive procedures and maternal thrombophilia. Haematologica 2003, 88:789-793.
37. Sanson BJ, Friederich PW, Simioni P, Zanardi S, Hilsman MV, Girolami A, ten Cate JW, Prins MH: The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost 1996, 75:387-388.
38. Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R: Hypercoagulable thrombophilia defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol 2001, 45:65-71.
39. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers CH, Eskes TK: Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resultingfrom low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998, 128:1336-1341.
40. Deitcher SR, Park VM, Kutteh WH: Methylene tetrahydrofolate reductase 677C-T mutation analysis in Caucasian women with early first trimester recurrent pregnancy loss. Blood 1998, 92(Suppl 1):117b.
41. Scholl TO, Johnson WG: Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 2000, 71(5 Suppl): 295S-1303S.
42. Pickering W, Holmes Z, Regan L, Cohen H: Normal prevalence of the G20210A prothrombin gene mutation in women with recurrent miscarriage. Br J Haematol 1998, 102:250.
43. Deitcher SR, Park VM, Kutteh WH: Prothrombin 20210 G-A mutation analysis in Caucasian women with early first trimester recurrent pregnancy loss. Blood 1998, 92(Suppl 1):118b.
44. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH: Geographic distribution of the 20210G to a prothrombin variant. Thromb Haemost 1998, 79:706-708.
45. Zivelin A, Rosenberg N, Faier S, Kornbrot N, Peretz H, Manhalter C, Horellow MH, Seligsohn U: A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998, 92:1119-1124.
46. Asherson RA, Cervera R: "Primary", "secondary" and other variants of the antiphospholipid syndrome. Lupus 1994, 3:293-298.